Veracyte Announces Appointment of Brent Shafer and Tom Miller, Ph.D., to Its Board
Veracyte, Inc. (Nasdaq: VCYT), a leading cancer diagnostics company, recently announced the appointment of Brent Shafer and Tom Miller, Ph.D., to its board of directors, effective immediately. “We are thrilled to welcome Brent and Tom to our board,” said Marc Stapley, Veracyte’s chief executive officer. “They are both seasoned business leaders with extensive healthcare industry […]
Prothena appoints Daniel G. Welch as Director and Chair Designate
Prothena Corporation plc, a late-stage clinical biotechnology company with a robust pipeline of investigational therapeutics built on protein dysregulation expertise, announced yesterday the appointment of Daniel G. Welch to its Board of Directors as an independent director and Chair Designate following a comprehensive search process in connection with the board’s regular succession planning. Upon election […]
Karuna Therapeutics onboards William P. Kane as CCO
Karuna Therapeutics, Inc. , a clinical-stage biopharmaceutical company driven to create and deliver transformative medicines for people living with psychiatric and neurological conditions, recently announces the appointment of Will Kane as chief commercial officer (CCO), effective February 6, 2023. “The addition of Will to our executive team represents an important step as we execute on […]
